These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4872691)

  • 41. [Distribution in the body of dogs of antibiotics of water soluble bases from Actinomycetes and indices of blood clearance of these antibiotics].
    Gol'dberg LE
    Antibiotiki; 1967 Jan; 12(1):27-33. PubMed ID: 4968831
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chemotherapy of purulent meningitis in childhood. I. Pharmacokinetics of antibacterial drugs in the cerebrospinal fluid].
    Scherber A; Henker J
    Kinderarztl Prax; 1982 Apr; 50(4):182-6. PubMed ID: 7109463
    [No Abstract]   [Full Text] [Related]  

  • 43. [Sensitivity to antibiotics of Staphylococci isolated from blood in non-specific bacteremias and sepsis].
    Proskurov VA; Strokatova NA
    Antibiotiki; 1970 Jun; 15(6):532-4. PubMed ID: 4917861
    [No Abstract]   [Full Text] [Related]  

  • 44. [Permeability of the hemato-encephalic barrier to antibiotics].
    DASTUGUE G; BASTIDE P
    Actual Pharmacol (Paris); 1958; 11():79-202. PubMed ID: 13626659
    [No Abstract]   [Full Text] [Related]  

  • 45. [Sensitivity of different Proteus species to antibiotics].
    Dikiĭ BN
    Antibiotiki; 1971 Jul; 16(7):622-4. PubMed ID: 4945575
    [No Abstract]   [Full Text] [Related]  

  • 46. Antimicrobial penetration into cerebrospinal fluid.
    Richards ML; Prince RA; Kenaley KA; Johnson JA; LeFrock JL
    Drug Intell Clin Pharm; 1981 May; 15(5):341-68. PubMed ID: 7023900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of purulent meningitis using Sigmamycin].
    Sidler Y
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1664-7. PubMed ID: 5363161
    [No Abstract]   [Full Text] [Related]  

  • 48. [Tobramycin concentrations in cerebrospinal fluid].
    Veyssier P; Carbon C; Boussougant Y; Mariel C; Lamotte-Barillon S; Domart A
    Nouv Presse Med; 1974 Apr; 3(0):66-8. PubMed ID: 4600181
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental and clinical data on the ability of bemetil to penetrate the hemato-encephalic barrier].
    Boĭko SS; Bobkov IuG; Dobrokhotova TA; Kniazeva NA; Neznamov GG
    Farmakol Toksikol; 1987; 50(3):79-81. PubMed ID: 3609285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of purulent bacterial meningitis].
    Bastin R; Vilde JL
    Acquis Med Recent; 1979; ():7-18. PubMed ID: 506680
    [No Abstract]   [Full Text] [Related]  

  • 51. [Fluorothane pharmaco kinetics in brain structures and the permeability of the hemato-encephalic barrier in postnatal ontogeny].
    Fateev VA; Saliaev VN; Titov NS
    Farmakol Toksikol; 1980; 43(1):41-3. PubMed ID: 7379989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The intrathecal antibiotic route in meningitis].
    Goitein K; Cividalli G; Shapiro T
    Harefuah; 1973 Aug; 85(4):165-7. PubMed ID: 4800691
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pronounced deafness after treatment with antibiotics of the neomycin group].
    Goncharenko NS
    Zh Ushn Nos Gorl Bolezn; 1965; 25(4):76. PubMed ID: 5337924
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of different doses of antibiotics on the antierysipeloid immunogenesis in experiment].
    Grezin VF; Kovalev VF
    Antibiotiki; 1967 Oct; 12(10):937-41. PubMed ID: 4871266
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of cyclopentane naphthenic acids and hydrocarbons on hemato-encephalic barrier permeability].
    Maĭzelis MIa; Kruglikov RI; Gaibov TD; Omarov IA; Zabludovskiĭ AL
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (2):61-3. PubMed ID: 6446198
    [No Abstract]   [Full Text] [Related]  

  • 56. Simultaneous determination of erythromycin ethylsuccinate and its metabolite erythromycin in human plasma using liquid chromatography-electrospray ionization mass spectrometry for clinical study.
    Gu Y; Wang G; Sun J
    J Pharm Biomed Anal; 2006 Feb; 40(3):737-43. PubMed ID: 16376051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neurospecific proteins and the function of the hemato-encephalic barrier in patients with meningococcal and pneumococcal infections].
    Lisukova TE; Chekhonin VP; Kashin AM; Broniakin IuV; Lidzhieva RTs; Koroteeva EA
    Ter Arkh; 1991; 63(11):71-3. PubMed ID: 1725682
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapy of suppurative meningitis].
    Wegmann T; Schmuziger P
    Ther Umsch; 1966 Mar; 23(3):108-12. PubMed ID: 5973984
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neonatal meningitis, ventriculitis, intraventricular therapy or not?].
    Schretlen E; Muytjens H; Slooff J
    Tijdschr Kindergeneeskd; 1985 Aug; 53(4):136-41. PubMed ID: 4082168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On the use of prodigiosan in combination with antibiotics for the treatment of acute and chronic inflammatory diseases of the cerebral membranes].
    Mad'iarov SD
    Antibiotiki; 1969 Jan; 14(1):86-9. PubMed ID: 4889840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.